Bank of New York Mellon’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-21,667
| Closed | -$11K | – | 4384 |
|
|
2020
Q4 | $11K | Hold |
21,667
| – | – | ﹤0.01% | 4204 |
|
|
2020
Q3 | $12K | Hold |
21,667
| – | – | ﹤0.01% | 4101 |
|
|
2020
Q2 | $15K | Sell |
21,667
-198,502
| -90% | -$160K | ﹤0.01% | 4065 |
|
|
2020
Q1 | $186K | Hold |
220,169
| – | – | ﹤0.01% | 3759 |
|
|
2019
Q4 | $361K | Buy |
220,169
+16,882
| +8% | +$25.3K | ﹤0.01% | 3732 |
|
|
2019
Q3 | $225K | Sell |
203,287
-12,246
| -6% | -$14.2K | ﹤0.01% | 3878 |
|
|
2019
Q2 | $268K | Buy |
215,533
+47,981
| +29% | +$61.1K | ﹤0.01% | 3839 |
|
|
2019
Q1 | $241K | Sell |
167,552
-644
| -0.4% | -$955 | ﹤0.01% | 3824 |
|
|
2018
Q4 | $198K | Hold |
168,196
| – | – | ﹤0.01% | 3858 |
|
|
2018
Q3 | $227K | Sell |
168,196
-1,761
| -1% | -$2.79K | ﹤0.01% | 3897 |
|
|
2018
Q2 | $389K | Buy |
169,957
+26,027
| +18% | +$50.3K | ﹤0.01% | 3746 |
|
|
2018
Q1 | $218K | Sell |
143,930
-3,967
| -3% | -$4.65K | ﹤0.01% | 3912 |
|
|
2017
Q4 | $113K | Sell |
147,897
-27,648
| -16% | -$24.7K | ﹤0.01% | 4070 |
|
|
2017
Q3 | $204K | Sell |
175,545
-1,101
| -0.6% | -$1.39K | ﹤0.01% | 3873 |
|
|
2017
Q2 | $307K | Sell |
176,646
-53,124
| -23% | -$113K | ﹤0.01% | 3808 |
|
|
2017
Q1 | $607K | Buy |
229,770
+5,451
| +2% | +$19.6K | ﹤0.01% | 3479 |
|
|
2016
Q4 | $953K | Buy |
224,319
+8,308
| +4% | +$27.4K | ﹤0.01% | 3287 |
|
|
2016
Q3 | $577K | Buy |
216,011
+36,940
| +21% | +$84.9K | ﹤0.01% | 3467 |
|
|
2016
Q2 | $317K | Buy |
179,071
+26,629
| +17% | +$54.3K | ﹤0.01% | 3725 |
|
|
2016
Q1 | $353K | Buy |
152,442
+6,845
| +5% | +$15.5K | ﹤0.01% | 3578 |
|
|
2015
Q4 | $504K | Buy |
145,597
+5,062
| +4% | +$24.2K | ﹤0.01% | 3522 |
|
|
2015
Q3 | $861K | Sell |
140,535
-36,487
| -21% | -$247K | ﹤0.01% | 3276 |
|
|
2015
Q2 | $1.17M | Buy |
177,022
+46,608
| +36% | +$314K | ﹤0.01% | 3244 |
|
|
2015
Q1 | $928K | Buy |
+130,414
| New | +$984K | ﹤0.01% | 3346 |
|
Other funds holding GEN
IC
TRCT
Bank of New York Mellon's GEN Position: Q1 2021 in Review
Bank of New York Mellon sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 21,667 shares — an estimated $11K sold.
Bank of New York Mellon first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $1.17M in Q2 2015. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.
- Bank of New York Mellon reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
- Bank of New York Mellon sold 21,667 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $11K.
- Bank of New York Mellon first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
- Bank of New York Mellon's Genesis Healthcare, Inc. position peaked at $1.17M in Q2 2015.
- 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.
Based on Bank of New York Mellon's 13F filing for Q1 2021, filed 13 May 2021.